Potential of E-Cigarettes to Improve Public Health: Expert Opinion

Sep.19.2022
Potential of E-Cigarettes to Improve Public Health: Expert Opinion
Tikki Pangestu believes e-cigarettes have potential to improve public health, citing data from independent UK studies.

Tikki Pangestu, a former director of policy research and cooperation at the World Health Organization, discussed the potential of e-cigarettes to improve public health. Professor Pangestu made a positive statement during an online discussion titled "Reducing Smoking Harm: Is it Possible to Reduce Tobacco Harm?


Professor Tikki Pang is currently a visiting professor at the Yong Loo Lin School of Medicine at the National University of Singapore. Prior to serving as Director of the World Health Organization, he was a professor at the Lee Kuan Yew School of Public Policy and a biomedical professor at the University of Malaya.


In his academic career spanning 30 years, Professor Peng has published over 250 scientific articles and 12 books covering topics such as epidemiology, pathogenesis, laboratory diagnosis, prevention of infectious diseases, biosafety, and dual-use research. He is recognized as an expert in public health both domestically and internationally.


According to Tikki Pang, there are still nearly 70 million smokers in his country, which has resulted in economic costs for the nation and significant socioeconomic burden for individuals.


He said, "From a public health and socio-economic perspective, this issue requires a strategic intervention and policy to reduce smoking rates in Indonesia.


Compared to products such as nicotine replacement therapy, interventions using products that promote harm reduction concepts are more effective for those who wish to quit smoking. This is a key strategy in addressing this highly complex issue. The products that result from technological advances and innovation have enormous potential.


Professor Peng cites facts and data from independent research in the UK to urge Indonesian lawmakers to accept electronic cigarettes, snus, and heated tobacco products.


The road to a healthier nation depends on the government ensuring that adult smokers have easy access to lesser harmful new nicotine products and that the information provided is accurate and truthful.


British cancer expert Peter Harper agrees with this. He commented, "You smoke to satisfy your need for nicotine, but you die from smoking. Quitting smoking immediately is one solution. However, current strategies are not effective. Innovative products provide solutions for those struggling to quit, while reducing the overall impact on well-being.


Statement:


This article is compiled from third-party information and is intended solely for communication and learning within the industry.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is only intended for industry exchange and research purposes.


Due to limitations in our translation abilities, the translated article may not perfectly reflect the original text. Please refer to the original article for accuracy.


2FIRSTS holds the same views and positions as the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and stances.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

 BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
BAT London Shares Gain 13.99% as FDA Vape Decision Draws Market Attention
British American Tobacco’s London-listed shares rose 13.99% last week, as investors focused on the U.S. Food and Drug Administration’s recent authorization of flavored Glas e-cigarette products, the dismissal of a U.S. sanctions-related criminal case against BAT, and the company’s previously announced share buyback plan and newer nicotine business performance.
BAT
May.18
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display
Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display
Ireland’s Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026 has passed final stage in the Dáil and will move to the Seanad, with measures to limit vape flavours to tobacco or unflavoured products and tighten rules on packaging colours, retail advertising, in-store displays and sales of nicotine pouches to minors.
News
Jun.26 by 2Firsts Perspectives
 Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
According to Reuters, Philip Morris International (PMI) lowered its 2026 adjusted earnings-per-share forecast amid regulatory uncertainty around Zyn nicotine pouches, rising competition and shipment pressure in the U.S. market.
PMI
Jun.02
2Firsts Interview | InterTabac 2026 Adapts to a More Complex Tobacco and Nicotine Market
2Firsts Interview | InterTabac 2026 Adapts to a More Complex Tobacco and Nicotine Market
As InterTabac 2026 approaches, Sabine Loos, Managing Director of Westfalenhallen Unternehmensgruppe, tells 2Firsts that global tobacco trade fairs are evolving beyond product display. With new nicotine categories, shifting regulation and more complex supply chains reshaping the industry, InterTabac is positioning itself as a platform for market insight, regulatory discussion and global business connection.
Special Report
Jul.02
German Environment Minister Plans Bill to Ban Disposable E-Cigarettes This Year
German Environment Minister Plans Bill to Ban Disposable E-Cigarettes This Year
German Federal Environment Minister Carsten Schneider said he is preparing legislation to ban disposable e-cigarettes and will present a bill this year. Industry data estimated that legal e-cigarette sales in Germany rose by about one quarter in 2025 to €2.4 billion. Refillable devices are not expected to be affected by the ban.
May.09 by 2FIRSTS.ai